Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
International Journal of Cancer|December 15, 2010
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphateSarah Jane Lunt, Simon Akerman, Sally A Hill, et al.The Lancet. Oncology|February 3, 2007
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I studyQuan-Sing Ng, Vicky Goh, Jessica Milner, et al.Microcirculation (New York, N.Y. : 1994)|October 24, 2007
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivoConstantino Carlos Reyes-Aldasoro, Ian Wilson, Vivien E Prise, et al.International Journal of Oncology|January 5, 2007
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-downKatharine J Lankester, Ross J Maxwell, R Barbara Pedley, et al.Advanced Drug Delivery Reviews|November 3, 2004
Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopyGillian M Tozer, Simon M Ameer-Beg, Jennifer Baker, et al.BMC Cancer|December 13, 2006
Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expressionGabi U Dachs, Andrew J Steele, Claudia Coralli, et al.The Journal of Clinical Investigation|April 15, 2011
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in miceAbigail F Welford, Daniela Biziato, Seth B Coffelt, et al.Genesis (New York, N.Y. : 2000)|August 29, 2012
Generation of a novel mouse model for the inducible depletion of macrophages in vivoNabeia Gheryani, Seth B Coffelt, Alison Gartland, et al.Cancer Research|April 6, 2017
Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in SarcomaWilliam R English, Sarah Jane Lunt, Matthew Fisher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2003
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imagingSusan M Galbraith, Ross J Maxwell, Martin A Lodge, et al.Pageof 6